Simultaneous LC-MS determination of glucose regulatory peptides secreted by stem cell-derived islet organoids
- PMID: 37574258
- DOI: 10.1002/elps.202300095
Simultaneous LC-MS determination of glucose regulatory peptides secreted by stem cell-derived islet organoids
Abstract
For studying stem cell-derived islet organoids (SC-islets) in an organ-on-chip (OoC) platform, we have developed a reversed-phase liquid chromatography-tandem mass spectrometry (RPLC-MS/MS) method allowing for simultaneous determination of insulin, somatostatin-14, and glucagon, with improved matrix robustness compared to earlier methodology. Combining phenyl/hexyl-C18 separations using 2.1 mm inner diameter LC columns and triple quadrupole mass spectrometry, identification and quantification were secured with negligible variance in retention time and quantifier/qualifier ratios, negligible levels of carryover (<2%), and sufficient precision (±10% RSD) and accuracy (±15% relative error) with and without use of an internal standard. The obtained lower limits of quantification were 0.2 µg/L for human insulin, 0.1 µg/L for somatostatin-14, and 0.05 µg/L for glucagon. The here-developed RPLC-MS/MS method showed that the SC-islets have an insulin response dependent on glucose concentration, and the SC-islets produce and release somatostatin-14 and glucagon. The RPLC-MS/MS method for these peptide hormones was compatible with an unfiltered offline sample collection from SC-islets cultivated on a pumpless, recirculating OoC (rOoC) platform. The SC-islets background secretion of insulin was not significantly different on the rOoC device compared to a standard cell culture well-plate. Taken together, RPLC-MS/MS method is well suited for multi-hormone measurements of SC-islets on an OoC platform.
Keywords: glucose regulatory hormones; liquid chromatography-tandem mass spectrometry; organ-on-chip; stem cell-derived islet organoids.
© 2023 The Authors. Electrophoresis published by Wiley-VCH GmbH.
References
REFERENCES
- 
    - Tang XY, Wu S, Wang D, Chu C, Hong Y, Tao M, et al. Human organoids in basic research and clinical applications. Signal Transduct Target Ther. 2022;7(1):168.
 
- 
    - Kim J, Koo BK, Knoblich JA. Human organoids: Model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21(10):571-84.
 
- 
    - Ingber DE. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 2022;23(8):467-91.
 
- 
    - Busek M, Aizenshtadt A, Koch T, Frank A, Delon L, Martinez MA, et al. Pump-less, recirculating organ-on-a-chip (rOoC) platform. Lab Chip. 2023;23:591-608.
 
- 
    - Lin A, Sved Skottvoll F, Rayner S, Pedersen-Bjergaard S, Sullivan G, Krauss S, et al. 3D cell culture models and organ-on-a-chip: meet separation science and mass spectrometry. Electrophoresis. 2020;41(1-2):56-64.
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
 
        